Periosteal osteosarcoma : A single-institution experience (pages 1731–1735)
Marilena Cesari, Marco Alberghini, Daniel Vanel, Emanuela Palmerini, Eric L. Staals, Alessandra Longhi, Massimo Abate, Cristina Ferrari, Alba Balladelli and Stefano Ferrari
Version of Record online: 8 NOV 2010 | DOI: 10.1002/cncr.25718
In this single-institution study, the authors examined the treatment of 33 patients who had periosteal osteosarcoma, a rare variant of osteosarcoma. The results indicated that surgery is the mainstay of treatment for these patients, and adjuvant chemotherapy is not required.